Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (18 total)
-
Autor: U.S. Food and Drug Administration
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2017-09-08
Descripción: This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major… -
Autor: U.S. Food and Drug Administration (FDA)
Tema: Research
Tipo de elemento: Guía
Fecha de actualización: 2018-08-13
Descripción: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here. -
Autor: University of Minnesota, Center for Infectious Disease Research and Policy
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2017-01-17
Descripción: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced. -
Autor: University of Nebraska Medical Center / Nebraska Medicine
Tema: General
Tipo de elemento: Webinar
Fecha de actualización: 2018-01-08
Descripción: Resources - National Ebola Training and Education CenterExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: Varkey, J. B. and B. S. Ribner
Tema: General
Tipo de elemento: Publicación
Fecha de actualización: 2016-06-01
Descripción: Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response. -
Autor: WHO
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2018-08-27
Descripción: A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1) -
Autor: Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2016-08-01
Descripción: From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: World Health Organization
Tema: General
Tipo de elemento: Guía
Fecha de actualización: 2022
Descripción: Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are…